TAF11L12

Across TCGA pan-cancer cohorts, TAF11L12 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated TAF11L12 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TAF11L12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TAF11L12 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

UCEC, CESC, and MESO are the cancer types where TAF11L12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	IV	0.225	0.772	<.001	42	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
MESO	DFS	Tertile	III,IV	0.181	0.389	.017	27	view →
BLCA	DFS	Tertile	III,IV	0.181	0.507	.002	24	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
COAD	DFS	Tertile	II,III,IV	1.000	0.472	.036	18	view →
STAD	DFS	Tertile	All	0.509	0.670	.021	18	view →
GBM	OS	Tertile	All	0.070	0.430	<.001	18	view →
LIHC	OS	Tertile	II,III,IV	0.118	0.696	.003	18	view →
CHOL	OS	Tertile	All	0.168	0.624	.019	9	view →
SKCM	OS	Tertile	IV	0.247	0.721	.038	9	view →
TGCT	DFS	Quartile	All	0.700	0.874	.041	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

TAF11L12–UCEC (OS)

Open the UCEC breakdown →